FSI's Q2 Net Income Soars 57% on R&D Services, H1 Sales Dip

Ticker: FSI · Form: 10-Q · Filed: Aug 14, 2025 · CIK: 1069394

Sentiment: mixed

Topics: Specialty Chemicals, Water Conservation, Biopolymers, R&D Services, Earnings Report, Revenue Diversification, Operating Income Growth

TL;DR

**FSI's Q2 net income jump is a mirage, fueled by one-off R&D services masking a product sales slump; stay cautious.**

AI Summary

FLEXIBLE SOLUTIONS INTERNATIONAL INC. (FSI) reported a mixed financial performance for the three and six months ended June 30, 2025. For the three months, total sales increased to $11,367,132 from $10,528,739 in the prior year, driven by $2,500,000 in research and development services, offsetting a decline in product sales from $10,528,739 to $8,867,132. Net income attributable to FSI rose significantly to $2,028,912, up from $1,289,796 in Q2 2024, representing a 57.3% increase. However, for the six months, total sales slightly decreased to $18,840,824 from $19,753,611 in the same period last year, primarily due to a drop in product sales from $19,753,611 to $16,340,824, partially mitigated by the new R&D service revenue. Net income attributable to FSI for the six months remained relatively flat at $1,751,178 compared to $1,747,022 in H1 2024. Operating income for the three months increased by 67.3% to $3,297,114, while for the six months, it grew by 18% to $3,227,957. Cash provided by operating activities decreased to $4,738,637 for the six months ended June 30, 2025, from $5,309,855 in the prior year.

Why It Matters

FSI's ability to leverage research and development services for a significant revenue stream, as seen with the $2,500,000 in Q2 2025, is crucial for investors, especially as product sales face headwinds. This diversification could provide a more stable revenue base and competitive edge against rivals in the specialty chemicals market. For employees, this shift might indicate a focus on innovation and new skill development. Customers could benefit from advanced product offerings resulting from these R&D efforts. The broader market will watch if this strategy can sustain growth and profitability, particularly given the slight decline in overall H1 sales and cash from operations, which could signal underlying challenges in their core product segments.

Risk Assessment

Risk Level: medium — The company's product sales declined by 15.7% for the three months ended June 30, 2025, from $10,528,739 to $8,867,132, and by 17.3% for the six months, from $19,753,611 to $16,340,824. While a $2,500,000 R&D service revenue boosted total sales and net income in Q2, the reliance on this potentially non-recurring revenue stream to offset core product weakness presents a medium-term risk to sustained growth and profitability.

Analyst Insight

Investors should scrutinize the sustainability of the research and development services revenue and its impact on future quarters. A deeper dive into the reasons for the product sales decline is warranted. Consider holding FSI shares if the R&D services prove to be a consistent, growing segment, but be prepared to trim positions if product sales continue to erode without a clear, long-term replacement strategy.

Financial Highlights

debt To Equity
N/A
revenue
$11,367,132
operating Margin
29.0%
total Assets
N/A
total Debt
N/A
net Income
$2,028,912
eps
$0.16
gross Margin
N/A
cash Position
$9,999,332
revenue Growth
+7.9%

Revenue Breakdown

SegmentRevenueGrowth
Research and Development Services$2,500,000+N/A%
Product Sales$8,867,132-15.7%
Product Sales$16,340,824-17.2%

Key Numbers

Key Players & Entities

FAQ

What drove Flexible Solutions International Inc.'s net income increase in Q2 2025?

Flexible Solutions International Inc.'s net income attributable to the company increased to $2,028,912 in Q2 2025 from $1,289,796 in Q2 2024, primarily due to $2,500,000 in research and development services revenue, which was not present in the prior year.

How did product sales perform for FSI in the first half of 2025?

Product sales for Flexible Solutions International Inc. decreased by 17.3% for the six months ended June 30, 2025, falling to $16,340,824 from $19,753,611 in the same period of 2024.

What is Flexible Solutions International Inc.'s strategic outlook regarding its TPA division?

The TPA division of Flexible Solutions International Inc. manufactures water-soluble chemicals, nitrogen conservation products, and food/nutritional materials. The company anticipates that this market vertical, which includes custom products for specific clients, will grow over time.

What are the key risks identified by Flexible Solutions International Inc. in its 10-Q filing?

Key risks for Flexible Solutions International Inc. include increased competitive pressures, rising interest rates, deteriorating economic conditions, adverse legislation or regulation, loss of customers, inability to achieve future sales levels, unavailability of funds for capital expenditures, operational inefficiencies, and new tariffs on raw materials from China.

How did FSI's cash flow from operations change in the first half of 2025?

Cash provided by operating activities for Flexible Solutions International Inc. decreased to $4,738,637 for the six months ended June 30, 2025, from $5,309,855 in the corresponding period of 2024.

What is the current number of outstanding common shares for Flexible Solutions International Inc.?

As of August 14, 2025, Flexible Solutions International Inc. had 12,656,532 common shares outstanding.

What is the purpose of Flexible Solutions International Inc.'s 80% interest in 317 Mendota LLC?

Flexible Solutions International Inc. purchased an 80% interest in 317 Mendota LLC to acquire a large manufacturing building. This allows ENP Investments to occupy part of the building, freeing up space in the ENP Peru building for NanoChem, and the company plans to rent the remaining space to suitable tenants.

How does Flexible Solutions International Inc. use its thermal polyaspartate biopolymers (TPAs)?

Flexible Solutions International Inc. uses TPAs to prevent corrosion and scaling in water piping for industries like petroleum, chemical, utility, and mining. TPAs also enhance fertilizers for crop yields and serve as additives in household laundry detergents, consumer care products, and pesticides.

What was Flexible Solutions International Inc.'s gross profit for the three months ended June 30, 2025?

Flexible Solutions International Inc. reported a gross profit of $5,385,266 for the three months ended June 30, 2025, an increase from $3,939,095 in the same period of 2024.

What is the nature of Flexible Solutions International Inc.'s water conservation products?

Flexible Solutions International Inc. markets HEATSAVR for swimming pools and spas to reduce energy by slowing water evaporation, and WATERSAVR for irrigation canals, aquaculture, and reservoirs to slow water loss due to evaporation.

Risk Factors

Industry Context

The specialty chemical and materials industry, where FSI operates, is characterized by innovation and evolving customer demands. Companies often diversify revenue streams to mitigate risks associated with specific product lines. The increasing importance of R&D services suggests a trend towards offering more value-added solutions beyond traditional product sales.

Regulatory Implications

As a publicly traded company, FSI is subject to SEC regulations and accounting standards (GAAP). Ensuring accurate and timely financial reporting, as presented in this 10-Q, is critical for compliance and investor confidence. Any misstatements or failures in disclosure could lead to regulatory scrutiny and penalties.

What Investors Should Do

  1. Monitor the sustainability and growth of the new R&D services revenue stream.
  2. Investigate the reasons behind the decline in product sales.
  3. Analyze the decrease in operating cash flow.

Glossary

Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Income (Loss)
These are financial statements that report a company's financial performance over a specific period (quarter or year-to-date) that has not been audited by an independent accountant. They include revenues, expenses, and profits/losses. (Provides the core profitability figures for FSI for Q2 and H1 2025, showing revenue, net income, and earnings per share.)
Cash provided by operating activities
This is a section of the cash flow statement that shows the amount of cash generated or used by a company's normal business operations over a period. (Indicates FSI's ability to generate cash from its core business, which is crucial for funding operations, investments, and debt repayment. The decrease in H1 2025 is a key point of analysis.)
Net Income Attributable to FSI
This represents the portion of the company's net income that belongs to the company's shareholders after accounting for any non-controlling interests. (Shows the bottom-line profitability available to FSI's shareholders, highlighting the significant increase in Q2 2025 and the flat performance over six months.)

Year-Over-Year Comparison

Compared to the prior year, FSI shows a mixed performance. Q2 2025 saw a significant 7.9% increase in total sales to $11,367,132, driven by new R&D services revenue, and a substantial 57.3% rise in net income to $2,028,912. However, this was partially offset by a decline in product sales. For the first six months of 2025, total sales slightly decreased to $18,840,824, with net income remaining relatively flat at $1,751,178. Operating cash flow also saw a decrease in H1 2025, indicating potential cash generation challenges despite improved quarterly profitability.

Filing Stats: 4,341 words · 17 min read · ~14 pages · Grade level 15.2 · Accepted 2025-08-14 16:01:59

Key Financial Figures

Filing Documents

Financial Statements

Financial Statements. 3 (a) Unaudited Condensed Interim Consolidated Balance Sheets at June 30, 2025 and December 31, 2024. 3 (b) Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months Ended June 30, 2025 and 2024. 4 (c) Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Income for the Six Months Ended June 30, 2025 and 2024. 5 (d) Unaudited Condensed Interim Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024. 6 (e) Unaudited Condensed Interim Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended June 30, 2025 and 2024. 7 (f) Notes to Unaudited Condensed Interim Consolidated Financial Statements for the Period Ended June 30, 2025. 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operation

Management's Discussion and Analysis of Financial Condition and Results of Operation. 19 Item 4.

Controls and Procedures

Controls and Procedures. 22 PART II. OTHER INFORMATION AND EXHIBITS 22 Item 5. Other Information. 22 Item 6. Exhibits . 22

SIGNATURES

SIGNATURES 23 1 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This document contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are "forward-looking statements" for the purposes of the federal and state securities laws, including, but not limited to: any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking "continue," "believe," "expect" or "anticipate" or other similar words. These forward-looking information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks and uncertainties include but are not limited to: Increased competitive pressures from existing competitors and new entrants; Increases in interest rates or our cost of borrowing or a default under any material debt agreement; Deterioration in general or regional economic conditions; Adverse

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing